Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
What Is Actos? Actos is a prescription diabetes medication distributed by Japan-based Takeda Pharmaceuticals Company Ltd., it’s active ingredient is, “Pioglitazone Hydrochloride”, it is used to help improve blood sugar control in adults with type two diabetes. Actos helps your body better use the insulin it makes and by stopping your liver from making sugar that [...]
Breaking News – Actos, the diabetes medication, shows great risk for bladder cancer Recently published research, from McGill University in Montreal, not only shows a direct link between using Actos and the risk of bladder cancer, but the research also proposes a possible explanation for the increased cancer risk. Actos is a drug used to [...]
Canada Adds Bladder Cancer Warning to Actos Label Canada Health warns public of bladder cancer risks and heart failure when using the diabetic drug Actos. In June of 2011 both France and Germany issued a recall on Takeda Pharmaceutical’s Actos. At that time Canada opted to wait and do a safety review on the diabetes drug. [...]
According to a Drug Safety Communication issued last week, the U.S. Food and Drug Administration announced it has approved the final language for the new Actos label. The drug’s label now includes warning language regarding the increased risk for bladder cancer in patients taking the medication for more than a year. The updated label also [...]
The Food and Drug Administration announced recently that prolonged use of Takeda Pharmaceutical’s diabetes drug, Actos (pioglitazone), may increase a patient’s risk for developing bladder cancer. The FDA also stated that product labeling would soon be updated to reflect the new information about the increased cancer risk. The warning was issued by the FDA following [...]
France’s drug authority announced on Thursday that it will suspend the use of two diabetes drugs, Actos and Competact, over concerns regarding cancer risks. The decision to issue the order for drug suspension came after the results of an official study conducted by the French Public Health Insurance Office revealed that the treatments were found [...]
